Haemonetics (HAE) Tops Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $75.12 -2.81%
Revenue Growth %: +2.3%
Financial Fact:
Net income: 0.39
Today's EPS Names:
DTGI, OCCI, MAYS, More
Revenue Growth %: +2.3%
Financial Fact:
Net income: 0.39
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $1.31, $0.06 better than the analyst estimate of $1.25. Revenue for the quarter came in at $338.97 million versus the consensus estimate of $331.91 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
- Methanex to idle Trinidad Titan plant after gas contract talks fail
- Jones Trading Starts Alterity Therapeutics (ATHE) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
